Founded in January of 2020, VREX Therapeutics is built upon the ground-breaking science of Prof. Dr. Feng Yao,  out of Harvard Medical School and Brigham and Women's Hospital.  VREX Therapeutics is driven to create new immunotherapy drugs that assist in treating and curing solid tumor cancers.

Biotechnology

VREX Therapeutics

Andrew F. Sandford

Q. Karen Zhu

Feng Yao

The current leadership team at VREX Therapeutics has a wealth of experience in the biotech industry. The President, Executive In Residence, and Strategic Advisor all come from different companies like ElevateBio, Anzu Partners, and Nature's Toolbox (NTx). They all have also have different types of education like a PhD in Chemistry or an MBA. However, what they all have in common is a passion for the biotech industry and a desire to help VREX be the best company it can be.

Leadership Team

About

Team members